News
BNR
0.7864
-7.49%
-0.0637
Burning Rock Biotech Announces ADS Ratio Adjustment
TipRanks · 10h ago
Burning Rock Biotech To Adjust ADS To Ordinary Share Ratio Effective May 15
Benzinga · 13h ago
Weekly Report: what happened at BNR last week (0415-0419)?
Weekly Report · 4d ago
Weekly Report: what happened at BNR last week (0408-0412)?
Weekly Report · 04/15 12:10
Weekly Report: what happened at BNR last week (0401-0405)?
Weekly Report · 04/08 12:16
Weekly Report: what happened at BNR last week (0325-0329)?
Weekly Report · 04/01 12:13
Burning Rock Biotech GAAP EPS of -$0.22, revenue of $17.1M
Burning Rock Biotech reported Q4 GAAP EPS of -$0.22, revenue of $17.1M. The company expects to achieve breakeven in the first half of 2024. Cash, cash equivalents, restricted cash were $86.7 million as of December 31, 2023.
Seeking Alpha · 03/29 06:47
BNR Stock Earnings: Burning Rock Biotech Reported Results for Q4 2023
Burning Rock Biotech just reported results for the fourth quarter of 2023. The company reported earnings per share of -22 cents and revenue of $17.05 million. InvestorPlace Earnings is a project that automates coverage of quarterly earnings reports to help readers understand the figures.
Investorplace · 03/29 02:52
Burning Rock Biotech’s 2023 Financial Dynamics
TipRanks · 03/28 22:27
Burning Rock Biotech Q4 EPS $(0.22) Up From $(0.31) YoY, Sales $17.10M Down From $20.62M YoY
Burning Rock Biotech reported quarterly losses of $0.22 per share. The company reported $17.10 million in sales for the quarter. This is a 17.08 percent decrease over sales of $20.62 million in the same period last year .
Benzinga · 03/28 21:23
Weekly Report: what happened at BNR last week (0318-0322)?
Weekly Report · 03/25 12:16
Earnings week ahead: Walgreens Boots Alliance, Carnival, GameStop and more
Several key companies are set to release their earnings reports for the week of March 25 to 29. Walgreens Boots Alliance, Carnival, GameStop and more are among the companies scheduled to report next week. The week is shortened by a market holiday on Friday and will be shortened to one day.
Seeking Alpha · 03/24 12:01
Denmark's Tyra gas field starts production, TotalEnergies says
NASDAQ · 03/22 08:48
Weekly Report: what happened at BNR last week (0311-0315)?
Weekly Report · 03/18 12:14
Weekly Report: what happened at BNR last week (0304-0308)?
Weekly Report · 03/11 12:09
Weekly Report: what happened at BNR last week (0226-0301)?
Weekly Report · 03/04 12:13
12 Health Care Stocks Moving In Thursday's After-Market Session
Cardiff Oncology (NASDAQ:CRDF) shares moved upwards by 28.6% to $2.27 during Thursday's after-market session. The company's, Q4 earnings came out today. Burning Rock Biotech stock rose 10.84% and Kineta shares increased by 20.6%.
Benzinga · 02/29 21:31
Weekly Report: what happened at BNR last week (0219-0223)?
Weekly Report · 02/26 12:33
Weekly Report: what happened at BNR last week (0212-0216)?
Weekly Report · 02/19 12:35
Weekly Report: what happened at BNR last week (0205-0209)?
Weekly Report · 02/12 12:20
More
Webull provides a variety of real-time BNR stock news. You can receive the latest news about Burning Rock Biotech Ltd through multiple platforms. This information may help you make smarter investment decisions.
About BNR
Burning Rock Biotech Ltd is a holding company mainly engaged in the next generation sequencing (NGS) based cancer therapy selection. The Company operates three segments. Central Laboratory Business segment is engaged in the sales of cancer therapy selection test to individual patients. In-Hospital Business segment is engaged in the sales of reagent kits and the provision of the facilitation services for the sale of laboratory equipment to hospitals. Pharma Research and Development Services segment provide services to companies primarily in relation to the development of targeted therapies and immunotherapies for various types of cancer, and to hospitals for their studies on cancer diagnosis and treatment. Its products include OncoScreen Plus and LungPlasma. Its NGS-based cancer therapy selection tests applicable to a broad range of cancer types, including lung cancer, prostate cancer, breast cancer and others. The Company mainly conducts its businesses in the China market.